Healthcare #healthcare executive with more than 30 years experience in operating and investing in companies. #VC Partner @EarlybirdVC

Hamburg
Joined March 2012
2022 was memorable! 🎢 We ran the numbers 📊 : 82 investments 💸 81 people on teams 👋 33 Earlybird's View articles ✍️ 3 Unicorns🦄 2 new offices 📍 1 mission to support European startups! ❤️‍🔥 👀 Year in Review w/ highlights across the family of funds: bit.ly/3HZ6U5d
3
7
2
36
10,781
Thom Rasche retweeted
We’ve entered into a strategic alliance with @abbvie. iSTAR Medical will receive a $60M non-dilutive upfront payment and AbbVie will hold the exclusive right to acquire iSTAR Medical at their discretion. More: bit.ly/3oiH5Ss #MIGS #MINIject #Glaucoma
1
3
7
🧬 Got a strong background in STEM? 🔬 Keen to explore a Career Beyond the Bench? 🔎 See more & apply for our Earlybird Health Fellowship bit.ly/3Azk6Ke #hiring #healthcare #investing #fellowship #EBVCteam @raschethom @hampshireUK @ChrisMassner @NasrallahRabab
5
2
10
Don't miss out on 5️⃣ key insights by Earlybird Health's @ChrisMassner on how #psychedelics could revolutionize #mentalhealth #treatment & why #VCs are investing in its research. 👀 a new Medium article👉🏽 bit.ly/3bpSlt8 w/ @raschethom, @NasrallahRabab & @ElishevaMarcus
3
7
2
16
Thom Rasche retweeted
Passen #KI-Medizinprodukte, #AIA und #EUMDR zusammen? Noch nicht ganz. Regulierungen müssen harmonisiert und die MDR KI-tauglich gestaltet werden, so die Expert:innen der Innovation Hall. Die KI-Vorteile in der Medizin zeigten sie mit Praxisbeispielen auf. bvmed.de/T/2022-06-23/medtec…
2
2
4
✍️New article in a Digital Health series: Maresa of Earlybird Digital West dives into the state of European #DigitalHealth Investments. She covers #VC activity & distribution across stages + countries. Discover her data-driven forecasts. 👀 👉🏽 bit.ly/3naKPVH #EBVCblog
For anyone trying to get into the VC space, this article is a must read 👇🏾cc:@ElishevaMarcus
"How can I break into VC?” Here's a complete guide.💥 In a new article, discover: ✔️ 4 proven ways to break into #VC ✔️ Benchmarks to highlight your edge ✔️ How to nail the VC #intern interview ✔️ What a VC intern does & learns ✔️ Exclusive #HR tips 👀 bit.ly/39AqqGn
1
1
3
Thom Rasche retweeted
At the #DOC2022, Prof. Dr med. Marc Schargus will present a meta-analysis from the STAR-I, II, III, trials on patients with open-angle #glaucoma implanted with #MINIject. More here: bit.ly/3zlkxHD #MIGS
1
1
There is no doubt: #Digital #Health investing is interesting and ambitious at the same time. How does it differ from #MedTech #investing? ➡️ Find my answer in this @MedTechStrat #article by @DCassak: bit.ly/3Nkx7KN
2
6
🇨🇭@TechTourHQ Health 2022 is returning for a 13th edition to Lausanne, #Switzerland. 🤝 Build long-lasting relationships with international #investors & #entrepreneurs in the #HealthTech field. 🗓June 21-22: Meet @ChrisMassner from Earlybird Health! 👉🏽 bit.ly/3MO32CT
1
2
Thom Rasche retweeted
Did you catch us at #EGS2022? The iSTAR Medical team thoroughly enjoyed the @EGUS_org congress in Athens. Find out more here: bit.ly/3FVmITr #MIGS #Ophthalmology #MINIject
1
1
„Viele [Startups] lernen gerade, dass es weniger um die Technologie und mehr um die Einführung eines Produkts in einen hochregulierten Gesundheitsmarkt geht“, so Thom Rasche @EarlybirdVC im @handelsblatt unter: handelsblatt.com/inside/digi…
2
4
1
13
"Many [startups] are just learning that it's less about the technology & more about launching a #product into a highly regulated #healthcare market." - @raschethom Partner, Earlybird Health 👀 @NasrallahRabab @ChrisMassner @LionelCarnot @hampshireUK @rolfmathies @ElishevaMarcus
„Viele [Startups] lernen gerade, dass es weniger um die Technologie und mehr um die Einführung eines Produkts in einen hochregulierten Gesundheitsmarkt geht“, so Thom Rasche @EarlybirdVC im @handelsblatt unter: handelsblatt.com/inside/digi…
🔬 Earlybird Health welcomes 🇫🇷@ImcheckThx to the #EBVCgang! ImCheck develops nextgen immunotherapeutic antibodies targeting gamma-delta T cells for treating solid & hematological #cancers, infectious & autoimmune #diseases. 👀 Series C 📰@FierceBiotech bit.ly/3zwrOEH
1
3
1
Thom Rasche retweeted
We presented a meta-analysis from 3 international clinical trials for #MINIject, the only commercially available supraciliary #MIGS device, at the 15th @EUGS_org Congress in Athens. More here: bit.ly/3hbjn #EGS2022
2
3
📣 Beyond the Bench Seminar by @MGPA & @harvardmed’s @MassGeneralNews is your #chance to discover #opportunities #beyondacademia. Join #healthcare #investing experts incl @NasrallahRabab of Earlybird Health 📍Thurs, 9 June 11:30pm CET/ 5:30pm EDT 👉🏽 Zoom bit.ly/3MjFZja
Hear from these speakers & many more on the 29-30 June 2022, at the first annual Bits & Pretzels HealthTech Conference hosted at ICM Munich.🎉 85% of our tickets have already sold out so the time to buy yours is now!🎟️ Link: bitsandpretzels.com/healthte… #bitshealth #bitsandpretzels
A @Jefferies survey explored impact of funding on R&D budgets: How will they change in new funding environments? What's the mindset of experienced #biotech investors? Join a call w/ Earlybird Health's @LionelCarnot to learn more! 📍Tue May 24 10am ET 👉🏽bit.ly/3Pv8r4i
2
1
“Oviva is one of the few #digitalcare delivery #startups operating in multiple European countries while being reimbursed by different (#healthcare) systems,” Our Principal @ChrisMassner on Earlybird Health's @OvivaHealth listed in @BusinessInsider 📰 👀 bit.ly/3Mzzbig
Super excited to announce the closing of Earlybird Digital West Fund VII – fueling European startups to achieve even more!🔥🚀 We're committed to innovation made in #Europe and grateful to our portfolio, investors, collaborators, team & community.🦄🦄 🔗📰👇🏽@TechCrunch, @faznet
4
2
2
30